It's part of a groundbreaking study being conducted in collaboration with Florida Atlantic University's (FAU) Institute for Human Health and Disease Intervention.
The Food and Drug Administration Friday approved a drug that doctors are calling the first treatment in decades that can slow the progression of Alzheimer’s disease.
Florida’s diverse elderly population is playing a key role in breakthrough Alzheimer’s research, contributing in a big way to the trials that led to the recent announcement of the first medicine to clearly blunt the progression of the disease.
Updated: 6:40 PM EDT May 6, 2021 Ari Hait Reporter Patrick Green loves to golf. The western Lake Worth, Florida, man has played all around the world.But a few years ago, his health did more than just threaten his golf game: It threatened everything about his life. One day, a little twitch in my thumb showed up. I was like, That’s weird that my thumb just twitches. And then it went to this, and then it went to this, Green said, showing his entire right arm shaking uncontrollably.Shortly after, Patrick was diagnosed with Parkinson’s disease.He found just bringing drinks to his wife at a restaurant could be a challenge. The shaking took over, and I spilled it all over somebody’s table, Green said. And they said, Well, set it down! And I said, I can t! I can t set it down! I just got so embarrassed. Green talked to several doctors before meeting neurologist Arif Dalvi and neurosurgeon Lloyd Zucker at Delray Medical Center.They introduced him